answer text |
<p>Recent analysis supports our understanding that the Pfizer/BioNTech and Moderna
vaccines, which are currently being deployed in the UK, appear to work well against
the current dominant variants of COVID-19 after a booster-dose. Continuing to administer
these vaccines at scale remains essential in our path out of the pandemic.</p><p>
</p><p>The Government continues to assess our existing vaccine portfolio against current
variants, working closely with vaccine manufacturers and the UK Health Security Agency
to understand the efficacy of our current vaccine portfolio against new variants.</p>
|
|